Cargando…

Nrf2-Mediated Metabolic Reprogramming in Cancer

Metabolic reprogramming is one of the hallmarks of cancer. Nrf2 pathway is one of the critical signaling cascades involved in cell defense and survival against oxidative stress. The significance of Nrf2 in cancer metabolism begins to be recognized. In this minireview, we focus on the Nrf2-mediated c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yan-Yang, Chen, Juan, Liu, Xiao-Ming, Zhao, Ren, Zhe, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833252/ https://www.ncbi.nlm.nih.gov/pubmed/29670683 http://dx.doi.org/10.1155/2018/9304091

Ejemplares similares

Nrf2 Mediates Metabolic Reprogramming in Non-Small Cell Lung Cancer
por: Zhao, Jiangang, et al.
Publicado: (2020)

Tamoxifen induces radioresistance through NRF2-mediated metabolic reprogramming in breast cancer
por: Naumann, F. V., et al.
Publicado: (2023)

NRF2 Orchestrates the Metabolic Shift during Induced Pluripotent Stem Cell Reprogramming
por: Hawkins, Kate E., et al.
Publicado: (2016)

Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer
por: Xu, Huan, et al.
Publicado: (2021)

Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment
por: Tan, Shiming, et al.
Publicado: (2023)

The role of YAP/TAZ activity in cancer metabolic reprogramming
por: Zhang, Xiaodong, et al.
Publicado: (2018)

Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy
por: Yan, Liang, et al.
Publicado: (2021)

Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells
por: Sreedhar, Annapoorna, et al.
Publicado: (2018)

Tumor metabolic reprogramming in lung cancer progression
por: Li, Xin, et al.
Publicado: (2022)

Immune cell metabolism and metabolic reprogramming
por: Hu, Chenchen, et al.
Publicado: (2022)

Metabolic reprogramming in macrophage responses
por: Liu, Yang, et al.
Publicado: (2021)

Role of Nrf2 in bone metabolism
por: Sun, Yong-Xin, et al.
Publicado: (2015)

LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancer
por: Tan, Yue‐Tao, et al.
Publicado: (2020)

Nuclear Receptor-Mediated Metabolic Reprogramming and the Impact on HR+ Breast Cancer
por: Hussein, Shaimaa, et al.
Publicado: (2021)

Metabolic Reprogramming and Its Regulatory Mechanism in Sepsis-Mediated Inflammation
por: Liu, Wenzhang, et al.
Publicado: (2023)

Metabolic reprogramming in cancer: Mechanisms and therapeutics
por: Nong, Shiqi, et al.
Publicado: (2023)

The cancer metabolic reprogramming and immune response
por: Xia, Longzheng, et al.
Publicado: (2021)

PKM2: The Thread Linking Energy Metabolism Reprogramming with Epigenetics in Cancer
por: Chen, Ling, et al.
Publicado: (2014)

Lipid metabolism reprogramming in head and neck cancer
por: Liang, Jinfeng, et al.
Publicado: (2023)

Nrf2 and HIF1α converge to arsenic-induced metabolic reprogramming and the formation of the cancer stem-like cells
por: Bi, Zhuoyue, et al.
Publicado: (2020)

Nrf2 activation reprograms macrophage intermediary metabolism and suppresses the type I interferon response
por: Ryan, Dylan G., et al.
Publicado: (2022)

Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming
por: Li, Zhenzhen, et al.
Publicado: (2021)

SOX2 Mediates Metabolic Reprogramming of Prostate Cancer Cells
por: de Wet, Larischa, et al.
Publicado: (2022)

Metabolic reprogramming in prostate cancer
por: Ahmad, Fahim, et al.
Publicado: (2021)

Nrf2 negatively regulates STING indicating a link between antiviral sensing and metabolic reprogramming
por: Olagnier, David, et al.
Publicado: (2018)

Lipid metabolic reprogramming in cancer cells
por: Beloribi-Djefaflia, S, et al.
Publicado: (2016)

Evolutionary Origins of Metabolic Reprogramming in Cancer
por: García-Sancha, Natalia, et al.
Publicado: (2022)

The Role of Reprogrammed Glucose Metabolism in Cancer
por: Ediriweera, Meran Keshawa, et al.
Publicado: (2023)

Application of Metabolic Reprogramming to Cancer Imaging and Diagnosis
por: Yang, Yi-Fang, et al.
Publicado: (2022)

Tubule-mitophagic secretion of SerpinG1 reprograms macrophages to instruct anti-septic acute kidney injury efficacy of high-dose ascorbate mediated by NRF2 transactivation
por: Ni, Yin, et al.
Publicado: (2022)

Inflexibility of AMPK-mediated metabolic reprogramming in mitochondrial disease
por: Lin, Dar-Shong, et al.
Publicado: (2017)

YAP and TAZ Mediators at the Crossroad between Metabolic and Cellular Reprogramming
por: Di Benedetto, Giorgia, et al.
Publicado: (2021)

Metabolic features of cancer cells in NRF2 addiction status
por: Okazaki, Keito, et al.
Publicado: (2020)

Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer
por: Li, Chunxia, et al.
Publicado: (2016)

The potential role of reprogrammed glucose metabolism: an emerging actionable codependent target in thyroid cancer
por: Duan, Sai-li, et al.
Publicado: (2023)

Reprogramming of fatty acid metabolism in cancer
por: Koundouros, Nikos, et al.
Publicado: (2019)

MicroRNA-Mediated Metabolic Reprograming in Renal Cancer
por: Bogusławska, Joanna, et al.
Publicado: (2019)

Cardiorenal protection of SGLT2 inhibitors—Perspectives from metabolic reprogramming
por: Gao, Yue-Ming, et al.
Publicado: (2022)

RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer
por: Li, Yi-Qun, et al.
Publicado: (2023)

Clinical significance of T cell metabolic reprogramming in cancer
por: Herbel, Christoph, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9hlna3jsljeechhulv829b1s6c